Gao Xiaolong, Hwang Tzyh-Chang
Dalton Cardiovascular Research Center and Departments of Biological Engineering and.
Dalton Cardiovascular Research Center and Departments of Biological Engineering and Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO 65211
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2461-6. doi: 10.1073/pnas.1420676112. Epub 2015 Feb 9.
Experimental and computational studies have painted a picture of the chloride permeation pathway in cystic fibrosis transmembrane conductance regulator (CFTR) as a short narrow tunnel flanked by wider inner and outer vestibules. Although these studies also identified a number of transmembrane segments (TMs) as pore-lining, the exact location of CFTR's gate(s) remains unknown. Here, using a channel-permeant probe, Au(CN)2, we provide evidence that CFTR bears a gate that coincides with the predicted narrow section of the pore defined as residues 338-341 in TM6. Specifically, cysteines introduced cytoplasmic to the narrow region (i.e., positions 344 in TM6 and 1148 in TM12) can be modified by intracellular Au(CN)2 in both open and closed states, corroborating the conclusion that the internal vestibule does not harbor a gate. However, cysteines engineered to positions external to the presumed narrow region (e.g., 334, 335, and 337 in TM6) are all nonreactive toward cytoplasmic Au(CN)2 in the absence of ATP, whereas they can be better accessed by extracellular Au(CN)2 when the open probability is markedly reduced by introducing a second mutation, G1349D. As Au(CN)2 and chloride ions share the same permeation pathway, these results imply a gate is situated between amino acid residues 337 and 344 along TM6, encompassing the very segment that may also serve as the selectivity filter for CFTR. The unique position of a gate in the middle of the ion translocation pathway diverges from those seen in ATP-binding cassette (ABC) transporters and thus distinguishes CFTR from other members of the ABC transporter family.
实验和计算研究描绘了一幅囊性纤维化跨膜传导调节因子(CFTR)中氯离子渗透途径的图景,即一条短而狭窄的通道,两侧是较宽的内部和外部前庭。尽管这些研究还确定了一些跨膜片段(TMs)构成孔道衬里,但CFTR门控的确切位置仍然未知。在这里,我们使用一种可透过通道的探针[Au(CN)₂]⁻,提供证据表明CFTR带有一个门控,该门控与预测的孔道狭窄部分重合,该狭窄部分定义为TM6中的338 - 341位残基。具体而言,在狭窄区域胞质侧引入的半胱氨酸(即TM6中的344位和TM12中的1148位)在开放和关闭状态下都能被细胞内的[Au(CN)₂]⁻修饰,这证实了内部前庭没有门控的结论。然而,在假定狭窄区域外部工程改造的半胱氨酸(例如TM6中的334、335和337位)在没有ATP的情况下对胞质[Au(CN)₂]⁻都没有反应,而当通过引入第二个突变G1349D使开放概率显著降低时,它们能更好地被细胞外的[Au(CN)₂]⁻接触。由于[Au(CN)₂]⁻和氯离子共享相同的渗透途径,这些结果表明沿着TM6在氨基酸残基337和344之间存在一个门控,该区域也可能是CFTR的选择性过滤器所在区域。门控在离子转运途径中间的独特位置与ATP结合盒(ABC)转运体中的情况不同,因此使CFTR区别于ABC转运体家族的其他成员。